Compounds > bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide
Page last updated: 2024-08-23

bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Parkinson Disease

bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antelman, SM; Caggiula, AR1
Reches, A1

Reviews

1 review(s) available for bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Parkinson Disease

ArticleYear
Noradrenergic influences on dopaminergic function and the pharmacology of dihydroxyphenylserine (DOPS): implication for Parkinson's disease.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:3

    Topics: Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Carbidopa; Dopamine; Droxidopa; Levodopa; Locus Coeruleus; Myocardium; Norepinephrine; Pargyline; Parkinson Disease; Serine; Stereoisomerism; Tyrosine

1985

Other Studies

1 other study(ies) available for bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Parkinson Disease

ArticleYear
Norepinephrine-dopamine interactions and behavior.
    Science (New York, N.Y.), 1977, Feb-18, Volume: 195, Issue:4279

    Topics: Aggression; Animals; Avoidance Learning; Behavior; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Dextroamphetamine; Dopamine; Dopamine beta-Hydroxylase; Feeding Behavior; Humans; Models, Neurological; Motor Activity; Neural Pathways; Norepinephrine; Parkinson Disease; Self Stimulation; Stereotyped Behavior; Stress, Physiological

1977